USA |NASDAQ |USD
| Report Date | Period Ending | EPS Forecast | Last Quarter's EPS | Last Year's EPS |
|---|---|---|---|---|
| Feb 28, 2022 | Dec 2021 | $-0.17 | - | $-0.20 |
| Report Date | Period Ending | Revenue Forecast | Last Quarter’s Revenue | Last Year’s Revenue |
|---|---|---|---|---|
| Feb 28, 2022 | Dec 2021 | $2.02M | - | $749.00K |
Agile Therapeutics, Inc's next earnings date is Monday, Feb 28, 2022 for the fiscal quarter ending Dec 2021.
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2021 | 4 | $-0.17 | $-0.23 | $-0.14 |
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2021 | 4 | $-0.76 | $-0.87 | $-0.69 |
| Dec 2022 | 4 | $-0.59 | $-0.93 | $-0.39 |
| Period End | Up/Down 1M | 1M Trend | 2M Trend | 3M Trend |
|---|---|---|---|---|
| Dec 2021 | 1 / 0 | $-0.18 | $-0.17 | $-0.15 |
| Period End | Up/Down 1M | 1M Trend | 2M Trend | 3M Trend |
|---|---|---|---|---|
| Dec 2021 | 1 / 0 | $-0.77 | $-0.76 | $-0.75 |
| Dec 2022 | 0 / 1 | $-0.55 | $-0.41 | $-0.30 |
| Period End | # of Analysts | Revenue Forecast | Low Revenue Forecast | High Revenue Forecast |
|---|---|---|---|---|
| Dec 2021 | 4 | $2.02M | $1.80M | $2.41M |
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2021 | 4 | $4.78M | $4.49M | $5.22M |
| Dec 2022 | 4 | $26.09M | $23.50M | $28.59M |
| Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
|---|---|---|---|---|
| Nov 2, 2021 | Sep 2021 | $-0.19 | - | - |
| Jul 26, 2021 | Jun 2021 | $-0.22 | $-0.20 | 7.41% |
| May 4, 2021 | Mar 2021 | $-0.22 | $-0.20 | 8.05% |
| Mar 1, 2021 | Dec 2020 | $-0.22 | $-0.20 | 10.71% |
| Nov 12, 2020 | Sep 2020 | $-0.18 | $-0.18 | -1.12% |
| Aug 11, 2020 | Jun 2020 | $-0.14 | $-0.12 | 14.29% |
| May 5, 2020 | Mar 2020 | $-0.09 | $-0.10 | -15.34% |
| Feb 20, 2020 | Dec 2019 | $-0.08 | $-0.10 | -33.33% |
| Oct 28, 2019 | Sep 2019 | $-0.08 | $-0.08 | 2.08% |
| Aug 1, 2019 | Jun 2019 | $-0.11 | $-0.08 | 27.27% |
| May 2, 2019 | Mar 2019 | $-0.10 | $-0.13 | -36.84% |
| Mar 12, 2019 | Dec 2018 | $-0.16 | $-0.10 | 34.19% |
| Nov 1, 2018 | Sep 2018 | $-0.15 | $-0.11 | 28.25% |
| Aug 3, 2018 | Jun 2018 | $-0.17 | $-0.14 | 12.85% |
| May 7, 2018 | Mar 2018 | $-0.20 | $-0.21 | -6.06% |
| Mar 12, 2018 | Dec 2017 | $-0.23 | $-0.18 | 21.26% |
| Nov 6, 2017 | Sep 2017 | $-0.25 | $-0.22 | 12.59% |
| Jul 28, 2017 | Jun 2017 | $-0.28 | $-0.26 | 5.80% |
| May 8, 2017 | Mar 2017 | $-0.30 | $-0.26 | 13.33% |
| Mar 8, 2017 | Dec 2016 | $-0.30 | $-0.18 | 40.79% |
| Nov 7, 2016 | Sep 2016 | $-0.34 | $-0.27 | 20.59% |
| Aug 8, 2016 | Jun 2016 | $-0.29 | $-0.29 | 0.58% |
| May 9, 2016 | Mar 2016 | $-0.36 | $-0.27 | 25.68% |
| Mar 9, 2016 | Dec 2015 | $-0.45 | $-0.17 | 62.22% |
| Nov 9, 2015 | Sep 2015 | $-0.42 | $-0.42 | - |
| Aug 13, 2015 | Jun 2015 | $-0.37 | $-0.38 | -2.70% |
| May 12, 2015 | Mar 2015 | $-0.34 | $-0.40 | -17.65% |
| Mar 26, 2015 | Dec 2014 | $-0.43 | $-0.37 | 13.95% |
| Nov 13, 2014 | Sep 2014 | $-0.50 | $-0.34 | 32.00% |
| Aug 14, 2014 | Jun 2014 | $-0.36 | $-0.28 | 22.22% |
| May 28, 2014 | Mar 2014 | - | $0.00 | - |
| Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
|---|---|---|---|---|
| Mar 1, 2021 | Dec 2020 | $-0.64 | $-0.60 | - |
| Feb 20, 2020 | Dec 2019 | $-0.35 | $-0.39 | - |
| Mar 12, 2019 | Dec 2018 | $-0.62 | $-0.57 | - |
| Mar 12, 2018 | Dec 2017 | $-0.97 | $-0.92 | - |
| Mar 8, 2017 | Dec 2016 | - | $-1.01 | - |
| Mar 9, 2016 | Dec 2015 | - | $-1.37 | - |
| Mar 26, 2015 | Dec 2014 | - | $-0.99 | - |
| Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
|---|---|---|---|---|
| Nov 2, 2021 | Sep 2021 | $1.46M | - | - |
| Jul 26, 2021 | Jun 2021 | $1.95M | $1.19M | 0.61% |
| May 4, 2021 | Mar 2021 | $160.00K | $116.00K | 0.73% |
| Mar 1, 2021 | Dec 2020 | $1.01M | $749.00K | 0.74% |
| Nov 12, 2020 | Sep 2020 | $0.00 | $0.00 | - |
| Aug 11, 2020 | Jun 2020 | $0.00 | $0.00 | - |
| May 5, 2020 | Mar 2020 | $0.00 | $0.00 | - |
| Feb 20, 2020 | Dec 2019 | $0.00 | $0.00 | - |
| Oct 28, 2019 | Sep 2019 | $0.00 | $0.00 | - |
| Aug 1, 2019 | Jun 2019 | $0.00 | $0.00 | - |
| May 2, 2019 | Mar 2019 | $0.00 | $0.00 | - |
| Mar 12, 2019 | Dec 2018 | $0.00 | $0.00 | - |
| Nov 1, 2018 | Sep 2018 | $0.00 | $0.00 | - |
| Aug 3, 2018 | Jun 2018 | $0.00 | $0.00 | - |
| May 7, 2018 | Mar 2018 | $0.00 | $0.00 | - |
| Mar 12, 2018 | Dec 2017 | $0.00 | $0.00 | - |
| Nov 6, 2017 | Sep 2017 | - | $0.00 | - |
| Jul 28, 2017 | Jun 2017 | - | $0.00 | - |
| May 8, 2017 | Mar 2017 | - | $0.00 | - |
| Mar 8, 2017 | Dec 2016 | - | $0.00 | - |
| Nov 7, 2016 | Sep 2016 | - | $0.00 | - |
| Aug 8, 2016 | Jun 2016 | - | $0.00 | - |
| May 9, 2016 | Mar 2016 | - | $0.00 | - |
| Mar 9, 2016 | Dec 2015 | - | $0.00 | - |
| Nov 9, 2015 | Sep 2015 | - | $0.00 | - |
| Aug 13, 2015 | Jun 2015 | - | $0.00 | - |
| May 12, 2015 | Mar 2015 | - | $0.00 | - |
| Mar 26, 2015 | Dec 2014 | - | $0.00 | - |
| Nov 13, 2014 | Sep 2014 | - | $0.00 | - |
| Aug 14, 2014 | Jun 2014 | - | $0.00 | - |
| May 28, 2014 | Mar 2014 | - | $0.00 | - |
| Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
|---|---|---|---|---|
| Mar 1, 2021 | Dec 2020 | $1.01M | $749.00K | -25.84% |
| Feb 20, 2020 | Dec 2019 | $0.00 | $0.00 | - |
| Mar 12, 2019 | Dec 2018 | $0.00 | $0.00 | - |
| Mar 12, 2018 | Dec 2017 | $0.00 | $0.00 | - |
| Mar 8, 2017 | Dec 2016 | - | $0.00 | - |
| Mar 9, 2016 | Dec 2015 | - | $0.00 | - |
| Mar 26, 2015 | Dec 2014 | - | $0.00 | - |
AGRX's next earnings date is Monday, Feb 28, 2022 for the fiscal quarter ending Dec 31, 2021.
According to analysts, the average EPS estimation for Agile Therapeutics, Inc's next quarterly earnings is $-0.17, with a low EPS estimation of $-0.23, and a high estimation of $-0.14.
Over the last 1 month, EPS estimates have seen 1 upward revisions and 0 downward. The EPS 1 month trend is $-0.18, the last 2 month trend is $-0.17, and the 3 month trend is $-0.15.
Based on analysts, the average revenue estimation is $2.02M, with a low revenue estimation of $1.80M, and a high estimation of $2.41M.
Agile Therapeutics, Inc's previous earnings date was Nov 2, 2021 for its fiscal quarter ended Sep 30, 2021.
Agile Therapeutics, Inc's previous annual earnings date was Mar 1, 2021 for its fiscal year ended Dec 31, 2020.
AGRX's earnings per share (EPS) was $-0.60, beating the consensus analysts forecast of $-0.64 by -6.25% , and lower than the previous year's EPS (Dec 2019) by 53.85%.
Revenues were $749.00K.
The company reported a net income of $-51.85M.
Agile Therapeutics, Inc reported a free cash flow of $-47.66M for its fiscal year, compared to $-15.79M a year ago.
The company ended the fiscal year with $16.52M in total debt, an increase of 9504.07% compared to the previous year.
Get a weekly snapshot of one new investment idea from stock exchanges worldwide.
